Westover et al., 2020 - Google Patents
Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancerWestover et al., 2020
View HTML- Document ID
- 7231529452172931628
- Author
- Westover K
- Mendel J
- Dan T
- Kumar K
- Gao A
- Pulipparacharuv S
- Iyengar P
- Nedzi L
- Hannan R
- Anderson J
- Choe K
- Jiang W
- Abdulrahman R
- Rahimi A
- Folkert M
- Laine A
- Presley C
- Cullum C
- Choy H
- Ahn C
- Timmerman R
- Publication year
- Publication venue
- Neuro-oncology
External Links
Snippet
Background Advanced radiotherapeutic treatment techniques limit the cognitive morbidity associated with whole-brain radiotherapy (WBRT) for brain metastasis through avoidance of hippocampal structures. However, achieving durable intracranial control remains …
- 210000004556 Brain 0 title abstract description 46
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/328—Health insurance management, e.g. payments or protection against fraud
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/103—Treatment planning systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1092—Details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1077—Beam delivery systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Westover et al. | Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancer | |
Rudra et al. | Using adaptive magnetic resonance image‐guided radiation therapy for treatment of inoperable pancreatic cancer | |
Foote et al. | Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy | |
Katz et al. | Stereotactic body radiotherapy for organ-confined prostate cancer | |
Yamazaki et al. | Reirradiation using robotic image-guided stereotactic radiotherapy of recurrent head and neck cancer | |
Hadi et al. | Stereotactic radiosurgery combined with targeted/immunotherapy in patients with melanoma brain metastasis | |
Kim et al. | Hippocampus-sparing whole-brain radiotherapy and simultaneous integrated boost for multiple brain metastases from lung adenocarcinoma: early response and dosimetric evaluation | |
Bander et al. | Durable 5-year local control for resected brain metastases with early adjuvant SRS: the effect of timing on intended-field control | |
McPherson et al. | Adjuvant whole-brain radiation therapy after surgical resection of single brain metastases | |
Ji et al. | Simultaneous integrated boost intensity-modulated radiotherapy for treatment of locally advanced non-small-cell lung cancer: a retrospective clinical study | |
Iwasaki et al. | A case of unresectable papillary thyroid carcinoma treated with lenvatinib as neoadjuvant chemotherapy | |
Shinoto et al. | Postoperative radiotherapy in patients with salivary duct carcinoma: clinical outcomes and prognostic factors | |
Chen et al. | Association between absolute volumes of lung spared from low-dose irradiation and radiation-induced lung injury after intensity-modulated radiotherapy in lung cancer: a retrospective analysis | |
Yang et al. | Intensity-modulated radiotherapy for gliomas: dosimetric effects of changes in gross tumor volume on organs at risk and healthy brain tissue | |
Onishi et al. | Case series of 23 patients who developed fatal radiation pneumonitis after stereotactic body radiotherapy for lung cancer | |
Ito et al. | Efficacy and toxicity of re-irradiation spine stereotactic body radiotherapy with respect to irradiation dose history | |
Lee et al. | Impact of conversion surgery on survival in locally advanced pancreatic cancer patients treated with FOLFIRINOX chemotherapy | |
Shi et al. | Stereotactic radiosurgery for pediatric and adult intracranial and spinal ependymomas | |
Lebow et al. | Early experience with hippocampal avoidance whole brain radiation therapy and simultaneous integrated boost for brain metastases | |
Tsurugai et al. | Stereotactic body radiotherapy for patients with non-small-cell lung cancer using RapidArc delivery and a steep dose gradient: prescription of 60% isodose line of maximum dose fitting to the planning target volume | |
Shrimali et al. | Impact of modern radiotherapy techniques on survival outcomes for unselected patients with large volume non-small cell lung cancer | |
Bas Ayata et al. | Comparison of multiple treatment planning techniques for high-grade glioma tumors near to critical organs | |
Armstrong et al. | Linac-based radiosurgery for patients with brain oligometastases from a breast primary, in the trastuzumab era-impact of tumor phenotype and prescribed SRS dose | |
Iizumi et al. | Acute toxicity and patient‐reported symptom score after conventional versus moderately hypofractionated proton therapy for prostate cancer | |
Gordon et al. | Upright proton therapy for esthesioneuroblastoma: a single-institution experience |